Chairing the conference is Professor M. Magdi Yaqoob MD; FRCP. Chair and Academic Director of Nephrology & Consultant in Nephrology, Barts Health NHS Trust UK. Professor in Centre for Translational Medicine & Therapeutics. Director, Centre for Diabetic Kidney Disease.
Muhammad Magdi Yaqoob is Professor of Nephrology within Centre for Translational Medicine & Therapeutics at the William Harvey Research Institute (WHRI) at Queen Mary College University of London, Academic Director of Department of Renal Medicine, Transplantation and Diabetic kidney Center at the Bart health NHS Trust, UK. He graduated as one of the best graduate in Medicine (1982) from Dow Medical College, Karachi University, Pakistan. After general professional clinical training during which he obtained membership of the Royal College of Physician London (1985) he started specialist nephrology training in Liverpool, UK in 1987. He obtained MD (research) and PhD in 1993 and 1995. He obtained NIH fellowship to work as postdoctoral clinician/scientist under Prof Robert Schrier at Denver Colorado (1994-1995). He joined the Royal London Hospital as consultant in January 1996 and was awarded personal chair in Nephrology by Queen Mary’s College, University of London in 2001. He received several awards (best European young investigator of the year 1992 and trainee investigator of the year by association of physicians USA, 1994). Professor Yaqoob is an internationally recognized expert in nephrology and transplant medicine in areas of cardiovascular diseases of uraemia including hypertension, accelerated aging, diabetic kidney disease, and renal anaemia, and renal bone disease, progression of chronic kidney disease and mediators of acute kidney injury. He has visiting professorships to several international universities.
Is diabetic bone disease another form of microvascular disease?
Prof Sir John Cunningham, Consultant Nephrologist, Royal Free London NHS Foundation Trust
John Cunningham is a clinician-scientist holding positions as Professor of Nephrology at University College London Medical School and The Royal Free Hospital and an Honorary Fellowship at Trinity Hall, University of Cambridge. His early training was in Cambridge and Oxford, with postgraduate training at The University of London and Washington University School of Medicine, St Louis, USA under Drs Louis V Avioli and Eduardo Slatopolsky. He has remained an active frontline clinician in nephrology and internal medicine and also worked as Physician to HM The Queen and Head of from 2005 to 2014.
SGLT2 inhibitors for the heart: more than just a diabetes drug?
Prof Lars Rydén, Senior Professor of Cardiology, The Karolinska Institute, Stockholm, Sweden
Lars Rydén is Senior Professor of Cardiology at the Karolinska Institute, Stockholm, Sweden. He specialises in internal medicine and cardiology, focusing on arrhythmias, cardiac pacing, heart failure and diabetes-related cardiovascular disease. He has published more than 700 scientific papers.
Full PowerPoint Presentation
Diabetes and it’s complications: Clinical case discussions
Prof Tahseen Chowdhury, DKC Deputy Clinical Director & Consultant, The Diabetic Kidney Care (DKC) Research Facility at Barts Health
Pre-event abstract
Diabetes is the commonest cause of end stage renal disease internationally. In this session, we hope to develop an interactive discussion of five real cases of patients with diabetes and complications, with the assistance of an expert panel and the audience. We hope the session will enable us to decide optimal management based on current evidence.
"Why is diabetes important? Retinopathy - commonest cause of blindness in people of working age. Cirrhosis - third commonest cause of cirrhosis worldwide. Cancer - x2 increased risk of colon, breast, pancreas and liver cancer. Stroke - x3 increased risk. Heart Disease - 75% of patients with diabetes die of ESRF. Nephropathy - commonest cause of ESRF. Foot problems - Commonest cause of amputation."